Biomarin Pharmaceutical Inc. · NASDAQ:BMRN
Viking Global Investors LP reported a 6.40% stake in Biomarin Pharmaceutical Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Viking Global Investors LP reported a 6.40% stake in Biomarin Pharmaceutical Inc., 12,288,611 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 6.40%
- Shares
- 12,288,611
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 13 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 6.40% | 12,288,611 |
| VIKING GLOBAL PERFORMANCE LLC | 4.30% | 8,208,825 |
| Viking Global Equities II LP | 0.10% | 164,175 |
| Viking Global Equities Master Ltd. | 4.20% | 8,044,650 |
| Viking Long Fund GP LLC | 1.50% | 2,856,671 |
| Viking Long Fund Master Ltd. | 1.50% | 2,856,671 |
| Viking Global Opportunities Parent GP LLC | 0.60% | 1,223,115 |
| Viking Global Opportunities GP LLC | 0.60% | 1,223,115 |
| Viking Global Opportunities Portfolio GP LLC | 0.60% | 1,223,115 |
| Viking Global Opportunities Liquid Portfolio Sub-Master LP | 0.60% | 1,223,115 |
| HALVORSEN OLE ANDREAS | 6.40% | 12,288,611 |
| Ott David C. | 6.40% | 12,288,611 |
| Shabet Rose Sharon | 6.40% | 12,288,611 |
Source
Related
- Biomarin Pharmaceutical Inc.
- Viking Global Investors LP
- Biomarin Pharmaceutical Inc. shareholders
- Schedule 13G/A · Viking Global Investors LP · Nov 14, 2025
- Form 4 · Friberg Gregory R · Oct 1, 2026
- Form 4 · Plenge Robert M · Sep 14, 2026
- Form 4 · Davis George Eric · Sep 3, 2026
- Form 4 · Countouriotis Athena · Jun 4, 2026
- Form 4 · Walbert Timothy P · Jun 4, 2026